CannaPharmaRX (CPMD) News Today $0.0085 0.00 (-15.00%) (As of 11/13/2024 05:36 PM ET) Add Compare Share Share Headlines Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period PSIQ Profile Solutions, Inc.August 16, 2024 | seekingalpha.comCannaPharmaRX, Inc. (CPMD)May 22, 2024 | finance.yahoo.comCannaPharmaRx to Host Investor Conference CallMay 20, 2024 | finance.yahoo.comCORRECTION FROM SOURCE: CannaPharmaRx to Host Investor Conference CallMay 20, 2024 | finance.yahoo.comCannapharmarx, Inc.: CannapharmaRx Receives First Purchase Order and Begins Shipment of ProductMarch 14, 2024 | finanznachrichten.deCannaPharmaRx, Inc.: CannaPharmaRx Completes First HarvestsMarch 12, 2024 | finanznachrichten.deCannapharmarx, Inc.: CannaPharmaRx to Hold Investor Conference CallMarch 7, 2024 | finanznachrichten.deCannapharmarx Partners With ICAN To Expand Cannabis Distribution In Latin AmericaMarch 5, 2024 | msn.comCannapharmarx, Inc.: CannaPharmaRx Executes Multi-Year Supply Agreement with ICAN to Create Distribution Network in the Latin AmericasMarch 5, 2024 | finanznachrichten.deCannapharmarx, Inc.: CannaPharmaRx Achieves IMC-GAP and GACP Certifications Completing a Significant Milestone Towards Revenue AccelerationFebruary 23, 2024 | finanznachrichten.deCannapharmarx, Inc.: CannaPharmaRx Finalizes Multi-Million Dollar Israeli Supply Agreement with CantekFebruary 16, 2024 | finanznachrichten.deCannaPharmaRx Finalizes Multi-Million Dollar Israeli Supply Agreement with CantekFebruary 16, 2024 | finance.yahoo.comCannapharmarx, Inc.: CannaPharmaRx CEO Provides Annual Update MessageFebruary 15, 2024 | finanznachrichten.deCannaPharmaRx CEO Provides Annual Update MessageFebruary 15, 2024 | stockhouse.comCannaPharmaRX, Inc. (CPMD) Stock Historical Prices & Data - Yahoo FinanceSeptember 10, 2023 | finance.yahoo.comCannapharmarx, Inc.: CannaPharmaRx Expands Board of DirectorsAugust 25, 2023 | finanznachrichten.deCannaPharmaRx Expands Board of DirectorsAugust 25, 2023 | finance.yahoo.comCannaPharmaRx Appoints Dean Medwid as New CEOJune 23, 2023 | finance.yahoo.comCannaPharmaRx Signs Agreement with Nasha GeneticsApril 19, 2023 | finance.yahoo.comCannaPharmaRX, Inc. (CPMD) stock historical prices & data – Yahoo FinanceApril 4, 2023 | uk.finance.yahoo.comCannaPharmaRx Signs Supply Agreement with Y.S.A Holdings for up to $15 Million Annually of Commercial CannabisMarch 30, 2023 | finance.yahoo.comCannaPharmRx, Inc. Completes Purchase of LTB Management, an E- Commerce and Financial Platform Company, and Launches New Corporate WebsiteMarch 21, 2023 | finance.yahoo.comCannaPharmRx, Inc. Adds to Revenue Streams by Purchasing E-Commerce and Financial Platform CompanyFebruary 21, 2023 | finance.yahoo.comCannaPharmaRx Evaluates Investigation into Market Manipulation and Potentially Illegal Trading of StockFebruary 1, 2023 | finance.yahoo.comCannaPharmaRx Releases Year-in-Review Letter to Shareholders and Discusses Revenue Opportunities for 2023January 30, 2023 | finance.yahoo.comCannaPharmaRx Receives Canada Revenue Agency (CRA) License As Final Step to Bringing Facility Into Production With Annual Revenues of Over $30 Million ExpectedJanuary 11, 2023 | finance.yahoo.comCanadian Cannabis; Down but Far from Out - Growth for 2023 and BeyondDecember 22, 2022 | finance.yahoo.comCannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Annual Revenue over $30 MillionDecember 21, 2022 | finance.yahoo.comCannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Revenue Over $30 MillionDecember 21, 2022 | finance.yahoo.comCannaPharmaRx Secures New Strains for Declaration to be Incorporated Into Product PortfolioDecember 19, 2022 | finance.yahoo.comCannaPharmaRx Files Response with Health Canada in Preparation for Cremona Facility Opening - Yahoo FinanceSeptember 7, 2022 | finance.yahoo.comCannaPharmaRx Files Response with Health Canada in Preparation for Cremona Facility OpeningSeptember 7, 2022 | finance.yahoo.com2022-09-07 | OTCPK:CPMD | Press Release | CannaPharmaRx Inc - StockhouseSeptember 7, 2022 | stockhouse.comCannaPharmaRx Signs Collaboration and Offtake Agreement with Spring Medical Group for Up to $12 Million of Commercial CannabisAugust 24, 2022 | finance.yahoo.comForm 10-Q CANNAPHARMARX, INC. For: Jun 30 - StreetInsider.comAugust 22, 2022 | streetinsider.comCPMD.PK - Cannapharmarx Inc | Stock Price & Latest News | ReutersAugust 16, 2022 | reuters.comCannaPharmaRx Enters into a Genetics Transfer Agreement with High Profile Cannabis Corp. - Yahoo FinanceJune 29, 2022 | finance.yahoo.comCannaPharmaRx Enters into a Genetics Transfer Agreement with High Profile Cannabis Corp.June 29, 2022 | finance.yahoo.comCalif. Man Cops To Medical Device Stock Pump Scam In EDNY - Law360May 13, 2022 | law360.comCANNAPHARMARX, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K) - Marketscreener.comApril 15, 2022 | marketscreener.comCannaPharmaRx Acquiring Oklahoma Cannabis FacilityFebruary 10, 2022 | finance.yahoo.comCannaPharmaRx Stops Issuing Shares Under Previously Effective S-1 - StreetInsider.comFebruary 9, 2022 | streetinsider.comCannaPharmaRx Stops Issuing Shares Under Previously Effective S-1February 8, 2022 | finance.yahoo.comCannaPharmaRx Enters into an Agreement for Supply of Genetics and Feed Stock to Accelerate Time to Market - StreetInsider.comJanuary 27, 2022 | streetinsider.comCannaPharmaRx Enters into an Agreement for Supply of Genetics and Feed Stock to Accelerate Time to Market - Yahoo FinanceJanuary 25, 2022 | finance.yahoo.comCannaPharmaRx Enters into an Agreement for Supply of Genetics and Feed Stock to Accelerate Time to MarketJanuary 25, 2022 | finance.yahoo.comCannaPharmaRx Hires Key Personnel to Accelerate Output and Speed to Market for Cannabis Product - Yahoo FinanceJanuary 19, 2022 | finance.yahoo.comCannaPharmaRx Hires Key Personnel to Accelerate Output and Speed to Market for Cannabis ProductJanuary 19, 2022 | finance.yahoo.comCannaPharmaRx Completes Long Term Lease for Cremona Production Facility Which Should Yield 6,000Kg ($30,000,000)/Year - Yahoo FinanceJanuary 6, 2022 | finance.yahoo.comCannaPharmaRx Completes Long Term Lease for Cremona Production Facility Which Should Yield 6,000Kg ($30,000,000)/YearJanuary 6, 2022 | finance.yahoo.com Get CannaPharmaRX News Delivered to You Automatically Sign up to receive the latest news and ratings for CPMD and its competitors with MarketBeat's FREE daily newsletter. Email Address I was wrong. Dead wrong. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. CPMD Media Mentions By Week CPMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CPMD News Sentiment▼0.000.55▲Average Medical News Sentiment CPMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CPMD Articles This Week▼00▲CPMD Articles Average Week Get CannaPharmaRX News Delivered to You Automatically Sign up to receive the latest news and ratings for CPMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GeoVax Labs News Today Enlivex Therapeutics News Today HST Global News Today MIRA Pharmaceuticals News Today Lisata Therapeutics News Today Cognition Therapeutics News Today Palatin Technologies News Today iBio News Today Bullfrog AI News Today Lakeshore Biopharma News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:CPMD) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersWhat are you hiding Elon?? (Tesla’s secret 69% dividend)Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CannaPharmaRX, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CannaPharmaRX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
